By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View Privacy Policy for more information.
360 DX: Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets
Written by
Fluxergy
Published on
January 25, 2021
The COVID-19 pandemic has shed light on the need for mass testing, particularly in areas that don't have access to centralized laboratories or trained technicians.
